Amneal Pharmaceuticals (AMRX) Stock News
$AMRX · NASDAQ · 2 stories in 30 daysBORSA has published 2 stories on Amneal Pharmaceuticals (AMRX) in the past 30 days. Amneal Pharmaceuticals’ next earnings report is scheduled for Tuesday, Nov 3 before the open.
The wire on $AMRX
newest first · updated · direct subject stories onlyOppenheimer initiates Amneal Pharmaceuticals at Outperform, target $27
Oppenheimer initiated coverage of Amneal Pharmaceuticals (AMRX) with an Outperform rating and a price target of $27. The initiation was announced September 23, 2026.
bullish 65 · impact 20Oppenheimer initiates Amneal Pharmaceuticals at outperform
Oppenheimer analysts initiated coverage of Amneal Pharmaceuticals with an Outperform rating. No price target was disclosed.
bullish 75 · impact 10The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
BORSAPLUSNews on Price · Earnings read · Flow and ownership · Options context
Create a free account · no card